# BenevolentAI vs Consensus

BenevolentAI records 0 monthly visits with 0% month-over-month growth and Contact for Pricing pricing. Consensus records 6,014,388 monthly visits with -1.2% growth and Freemium pricing.

| Metric | [BenevolentAI](https://openaitools.app/tool/benevolent-ai) | [Consensus](https://openaitools.app/tool/consensus) |
| :--- | :--- | :--- |
| Website URL | https://benevolent.ai | https://consensus.app |
| Categories | AI Healthcare, AI Research Tool, AI Knowledge Graph | AI Search Engine, AI Research Tool, AI Papers, AI Article Summarizer |
| Pricing Model | Contact for Pricing | Freemium |
| Monthly Visits | 0 | 6,014,388 |
| MoM Growth Rate | 0% | -1.2% |
| Primary Market | Global | United States |
| Direct Visits | 0 | 2,918,713 |
| Review Score | 4.3 | 4.7 |
| Saved Count | 0 | 31 |
| Supported Platforms | Website | Website |

## BenevolentAI

BenevolentAI is a biopharma technology company that applies advanced artificial intelligence to the discovery of new medicines and to life science intelligence. Its foundation is a decade-long investment in a proprietary biomedical knowledge graph and set of ontologies, which give machine learning models a structured, curated view of scientific knowledge to reason over.

The company brings together science and technology teams who work with partners to embed AI into real drug-discovery workflows — from hypothesis generation and target identification to prioritising mechanisms worth pursuing. BenevolentAI also offers Qor, an always-on strategic function that helps biopharma decision makers and life science consultancies draw insight from scientific data.

BenevolentAI is headquartered in Luxembourg and listed on Euronext Amsterdam under the ticker BAI. Because its work is enterprise-focused, access and scope are arranged directly with the company rather than through self-serve plans.

**Pricing & Plans:** Contact for pricing. BenevolentAI does not publish public plans; access to its drug-discovery platform and the Qor intelligence offering is arranged directly with the company.

- **Biomedical knowledge graph:** A decade of investment in a proprietary biomedical knowledge graph and ontologies that structure scientific data for machine learning.
- **AI-driven drug discovery:** Apply AI and machine learning to identify and prioritise promising drug targets and mechanisms.
- **Qor life science intelligence:** An always-on strategic function that turns life science data into insight for biopharma decision makers and consultancies.
- **Science-first collaboration:** Teams of scientists and engineers work with partners to embed cutting-edge AI into real R&D workflows.

**Strengths:** Deep, longstanding investment in a curated biomedical knowledge graph and ontologies; Combines scientific and engineering expertise in one organisation; Applies AI to concrete drug-discovery and R&D decisions rather than generic tasks; Listed, established company with an enterprise track record in biopharma

**Limitations:** No self-serve sign-up or transparent pricing — engagement starts with a sales conversation; Deeply specialised for biopharma R&D, so it is not useful outside life sciences; Outputs are decision-support insights that still require expert scientific validation; Access and scope are shaped by enterprise partnership terms rather than open plans

[Profile (Markdown)](https://openaitools.app/tool/benevolent-ai.md)

## Consensus

Consensus works like a scholarly search engine supercharged by AI. Instead of returning a flat list of PDFs, you ask a natural-language research question and Consensus extracts claims from relevant papers, then shows you what the studies actually find. A Consensus Meter summarizes the weight of evidence for yes/no questions, so you can see at a glance whether scientists largely agree, disagree, or remain divided.

The platform indexes hundreds of millions of peer-reviewed papers spanning medicine, biology, psychology, economics and more. Answers link straight back to the source studies, and you can filter by study design, journal quality, sample size and publication year to separate stronger evidence from weaker signals. Features like Deep Search, Topic Synthesis and Skills let researchers build a working knowledge base over time rather than starting from scratch on every query.

Consensus is designed for researchers, clinicians, students and analysts who need trustworthy signals from the scientific record without drowning in irrelevant results. A free tier gives limited AI-powered searches each month, while paid plans unlock unlimited use, advanced filters and deeper synthesis.

**Pricing & Plans:** Freemium. A free tier offers a limited number of AI-powered searches per month; paid individual plans unlock unlimited searches and advanced research features, with discounted student pricing and team/enterprise options.

- **Evidence-grounded answers:** Ask a research question in plain language and get answers synthesized from peer-reviewed studies, with each claim linked to its source paper.
- **Consensus Meter:** A visual summary shows how the scientific literature leans on a yes/no question, indicating agreement, disagreement or mixed evidence.
- **Powerful filters:** Narrow results by study design, sample size, journal quality, publication year and more to prioritize high-quality evidence.
- **Topic synthesis and Deep Search:** Aggregate findings across many studies into structured summaries that map what is known and where the gaps are.
- **Research workspace:** Save papers, organize sources and build a persistent knowledge base for literature reviews and ongoing projects.

**Strengths:** Answers cite real peer-reviewed papers, so claims are verifiable; Consensus Meter makes it easy to gauge scientific agreement at a glance; Rich filters help separate high-quality evidence from weaker studies; Fast, clean interface designed around research workflows

**Limitations:** Free tier caps the number of AI-assisted searches per month; Coverage is strongest for STEM and health fields, lighter for some humanities topics; It guides you toward sources but is not a substitute for reading full papers

[Profile (Markdown)](https://openaitools.app/tool/consensus.md)

## Frequently Asked Questions

### How do BenevolentAI and Consensus compare in monthly traffic?

BenevolentAI has 0 monthly visits, while Consensus has 6,014,388. Traffic estimates describe audience size, not product quality.

### How do their growth rates compare?

BenevolentAI has a month-over-month growth rate of 0%; Consensus has -1.2%.

### How does pricing compare?

BenevolentAI: Contact for Pricing. Contact for pricing. BenevolentAI does not publish public plans; access to its drug-discovery platform and the Qor intelligence offering is arranged directly with the company. Consensus: Freemium. Freemium. A free tier offers a limited number of AI-powered searches per month; paid individual plans unlock unlimited searches and advanced research features, with discounted student pricing and team/enterprise options.

## Alternatives

| # | Tool Name | Monthly Visits | MoM Growth Rate | Pricing Model | Summary | Profile (Markdown) |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | [Perplexity](https://openaitools.app/tool/perplexity-ai) | 88,310,223 | -3.7% | Freemium | Covers general web sources alongside academic papers, but lacks specialized scientific synthesis metrics and consensus ratings. | [.md](https://openaitools.app/tool/perplexity-ai.md) |
| 2 | [Semantic Scholar](https://openaitools.app/tool/semantic-scholar) | 8,198,672 | +5.8% | Free | Completely free access to a massive scholarly index, but offers less automated natural-language evidence synthesis than Consensus. | [.md](https://openaitools.app/tool/semantic-scholar.md) |
| 3 | [Kagi Search](https://openaitools.app/tool/kagi-search) | 4,647,605 | +3.2% | Free Trial, Paid | A paid, ad-free search engine that answers to its users | [.md](https://openaitools.app/tool/kagi-search.md) |
| 4 | [SciSpace](https://openaitools.app/tool/scispace) | 4,464,111 | +8.6% | Freemium | Provides deeper PDF reading and interactive literature analysis tools, but is less focused on quick evidence aggregation. | [.md](https://openaitools.app/tool/scispace.md) |
| 5 | [Branded](https://openaitools.app/tool/gobranded-com) | 3,704,728 | +6.6% | Contact for Pricing | Targeted research audiences with AI-verified data quality | [.md](https://openaitools.app/tool/gobranded-com.md) |
| 6 | [Elicit](https://openaitools.app/tool/elicit) | 1,751,507 | +3.1% | Freemium | Performs advanced systematic review data extraction and evidence synthesis, but has a more complex interface than Consensus. | [.md](https://openaitools.app/tool/elicit.md) |
| 7 | [Jenni](https://openaitools.app/tool/jenni) | 1,498,133 | +5.2% | Freemium | The AI workspace where researchers read, write, and cite with every claim traceable to its source | [.md](https://openaitools.app/tool/jenni.md) |
| 8 | [Rayyan](https://openaitools.app/tool/rayyan) | 1,116,437 | +7.9% | Freemium | AI-assisted systematic review software for screening, extraction, and evidence synthesis at scale | [.md](https://openaitools.app/tool/rayyan.md) |
| 9 | [Scite](https://openaitools.app/tool/scite) | 841,974 | +1.1% | Free Trial, Contact for Pricing | Tracks how papers are cited with Smart Citations to gauge reliability, but features a less direct Q&A synthesis. | [.md](https://openaitools.app/tool/scite.md) |
| 10 | [ResearchRabbit](https://openaitools.app/tool/researchrabbit) | 831,571 | +3.1% | Free | Excellent for visual citation mapping and literature discovery, but lacks automated paper Q&A and evidence synthesis. | [.md](https://openaitools.app/tool/researchrabbit.md) |

---
Source: https://openaitools.app/compare/benevolent-ai-vs-consensus

More Markdown: [Categories](https://openaitools.app/categories.md) · [Traffic rankings](https://openaitools.app/rankings.md) · [llms.txt](https://openaitools.app/llms.txt)
